| Chronic Myelomonocytic Leukemia-2 studied in …STUDIED_INderived9 of 9 |
|---|
| → studied in | NCT04734990Phase 1/Phase 2 · active not recruiting Seclidemstat and Azacitidine for the Treatment of Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia · condition mapped ONTOLOGY_EXACT · 9 trials mapped (6 active) | — | — | Chronic Myelomonocytic Leukemia-2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01522976Phase 2 · active not recruiting Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia · condition mapped ONTOLOGY_EXACT · 9 trials mapped (6 active) | — | — | Chronic Myelomonocytic Leukemia-2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05038592Phase 1/Phase 2 · active not recruiting Phase I/II Study of Tagraxofusp in Combination With Decitabine for Patients With Myelomonocytic/Myeloproliferative Neoplasm and High Risk Myelodysplastic Syndromes · condition mapped ONTOLOGY_EXACT · 9 trials mapped (6 active) | — | — | Chronic Myelomonocytic Leukemia-2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04771572Phase 1 · recruiting Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL. · condition mapped ONTOLOGY_EXACT · 9 trials mapped (6 active) | — | — | Chronic Myelomonocytic Leukemia-2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06950034Phase 1 · recruiting A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML) · condition mapped ONTOLOGY_EXACT · 9 trials mapped (6 active) | — | — | Chronic Myelomonocytic Leukemia-2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05584761Phase 1/Phase 2 · recruiting Unrelated Umbilical Cord Blood Stem Cell Combined With Azacitidine Based Treatment for Advanced MDS,CMML-2 and sAML · condition mapped ONTOLOGY_EXACT · 9 trials mapped (6 active) | — | — | Chronic Myelomonocytic Leukemia-2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02756572Phase 2 · completed Early Allogeneic Hematopoietic Cell Transplantation in Treating Patients With Relapsed or Refractory High-Grade Myeloid Neoplasms · condition mapped ONTOLOGY_EXACT · 9 trials mapped (6 active) | — | — | Chronic Myelomonocytic Leukemia-2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02029950Phase 1 · completed Pomalidomide After Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 9 trials mapped (6 active) | — | — | Chronic Myelomonocytic Leukemia-2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02121418NA · completed Decitabine and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, or Myeloproliferative Neoplasm · condition mapped ONTOLOGY_EXACT · 9 trials mapped (6 active) | — | — | Chronic Myelomonocytic Leukemia-2 | 1 | Observed | clinicaltrials | graph → |